Nexgel NXGLW
NASDAQ NXGLW
$0.02 +0.01 (+100.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Nexgel (NXGLW) Cash from Financing Activities (2018 - 2025)

Nexgel's (NXGLW) quarterly Cash from Financing Activities came in at -$1.0 million in Q4 2025, down 162.34% YoY from $1.7 million in Q4 2024, and down 154.05% on a QoQ basis from $1.9 million in Q3 2025.

Nexgel (NXGLW) Cash from Financing Activities (2018 - 2025) Analysis & Trends

Nexgel (NXGLW) has 8 years of Cash from Financing Activities data on file, last reported at -$1.0 million in Q4 2025.

  • Quarterly Cash from Financing Activities fell 162.34% year-over-year to -$1.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $630000.0 (down 83.2% YoY) and the FY2025 annual result came in at $630000.0, down 83.2% from the prior year.
  • Cash from Financing Activities fell to -$1.0 million in Q4 2025, from $1.9 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $13.2 million in Q4 2021 to a low of -$2.0 million in Q1 2022.
  • A 5-year average of $968666.7 and a median of $43500.0 in 2023 frame the typical range for Cash from Financing Activities.
  • The widest YoY moves for Cash from Financing Activities: up 46550.0% in 2024, down 6300.0% in 2024.
  • Tracing NXGLW's Cash from Financing Activities over 5 years: stood at $13.2 million in 2021, then tumbled by 101.14% to -$150000.0 in 2022, then jumped by 296.0% to $294000.0 in 2023, then soared by 468.03% to $1.7 million in 2024, then tumbled by 162.34% to -$1.0 million in 2025.
  • The last three Cash from Financing Activities figures came in at -$1.0 million (Q4 2025), $1.9 million (Q3 2025), and -$40000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn -287.90 Mn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -577.00 Mn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -510.00 Mn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn -263.16 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn -159.00 Mn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -164.80 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -300.00 Mn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -75.80 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -31.00 Mn
10 Nexgel 194,000.44 -994,999.56 1.11 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.04 Mn
Dec 31, 2025 -1.04 Mn
Sep 30, 2025 1.93 Mn
Sep 30, 2025 1.93 Mn
Jun 30, 2025 -40,000.00
Jun 30, 2025 -40,000.00
Mar 31, 2025 -215,000.00
Mar 31, 2025 -215,000.00
Dec 31, 2024 1.67 Mn
Dec 31, 2024 1.67 Mn
Sep 30, 2024 1.21 Mn
Sep 30, 2024 1.21 Mn
Jun 30, 2024 -64,000.00
Jun 30, 2024 -64,000.00
Mar 31, 2024 929,000.00
Mar 31, 2024 929,000.00
Dec 31, 2023 294,000.00
Dec 31, 2023 294,000.00
Sep 30, 2023 88,000.00
Sep 30, 2023 88,000.00